Joseph Donzelli, MD
Otolaryngology · Naperville, ILNPI 1508938952
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,212 of the $10,321 with a category attached, or 69.9%. 33 manufacturers reported payments, led by Intersect ENT, Inc. at 30.6% of the total. Among otolaryngology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 293 payments — averaging $35.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- KARL Storz Endoscopy-america$1K
- Sanofi$837
- GSK$814
- Optinose US, Inc.$739
- Amneal Pharmaceuticals LLC$579
- plus $3K from 27 others
What the payments were for
- Travel & lodging$2,98229%
- Food & beverage$7,21270%
- Education$1271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 16 | $3,155 |
| KARL Storz Endoscopy-america | 4 | $1,126 |
| Sanofi | 25 | $837 |
| GSK | 38 | $814 |
| Optinose US, Inc. | 50 | $739 |
| Amneal Pharmaceuticals LLC | 33 | $579 |
| Regeneron Healthcare Solutions, Inc. | 17 | $427 |
| IBSA Pharma Inc. | 20 | $351 |
| AbbVie | 18 | $308 |
| Acclarent, Inc | 3 | $295 |
| Alk-abello, Inc | 15 | $247 |
| Hologic Sales And Service, LLC | 4 | $191 |
| Stryker | 5 | $189 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $155 |
| Kaleo, Inc. | 6 | $105 |
| Inspire Medical Systems, Inc. | 5 | $104 |
| Medtronic | 4 | $96 |
| Cochlear Americas | 1 | $94 |
| Amgen | 3 | $69 |
| Kerecis Limited | 2 | $53 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| AstraZeneca | 2 | $49 |
| Baxter Healthcare | 1 | $47 |
| Novartis | 2 | $45 |
| Merck | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| Aerin Medical Inc. | 1 | $21 |
| Checkpoint Surgical, Inc | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
| Bolder Surgical LLC | 1 | $12 |
| Glenmark Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$2,831
- SINUVA$2,467
- DUPIXENT$431
- TruDi Nav Cable$238
- CoolSeal Generator$129
- Acclarent Aera$119
- Relieva Spinplus$119
- Relieva Tract$119
- NUCALA$116
- Xhance$115
How this compares
$10,321 in reported general payments places this provider in the 90th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 20 | $12,348 |
| Azelastine Hcl | 487 | $11,795 |
| SynthroidLevothyroxine Sodium | 100 | $7,243 |
| Levothyroxine Sodium | 525 | $5,869 |
| Ipratropium Bromide | 76 | $1,977 |
| UnithroidLevothyroxine Sodium | 55 | $1,962 |
| Epinephrine | 11 | $1,304 |
| Fluticasone Propionate | 51 | $962 |
| Liothyronine Sodium | 26 | $776 |
| Famotidine | 67 | $510 |
| Montelukast Sodium | 36 | $429 |
| Acetic Acid | 22 | $394 |
| Mupirocin | 52 | $371 |
| Cefdinir | 23 | $354 |
| Omeprazole | 13 | $264 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $739 | $12,34820 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $579 | $7,831580 claims |
| AbbVieSynthroid | $308 | $7,243100 claims |
| Hikma Pharmaceuticals USAEpinephrine | $31 | $1,30411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 390 otolaryngology providers in Illinois.
Other otolaryngology in Naperville
- Akta KakodkarNaperville$7K
- Ryan BurgetteNaperville$5K
- David ConleyChicago$630K
- Jayant PintoChicago$628K
- Robert KernChicago$610K
- Robert NaclerioBurr Ridge$229K
- Michael HutzOak Park$103K
- Charles WeingartenGlenview$96K
- Victoria LeeChicago$86K
- Louis PortugalChicago$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.